WuXi Biologics (Cayman) Inc
HKEX:2269
WuXi Biologics (Cayman) Inc
HKEX:2269
Price:
34.42
HKD
-1.99%
Market Closed
Market Cap:
HK$142.4B
Relative Value
The Relative Value of one
WuXi Biologics (Cayman) Inc
stock under the Base Case scenario is
31.72
HKD.
Compared to the current market price of 34.42 HKD,
WuXi Biologics (Cayman) Inc
is
Overvalued by 8%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
31.72
HKD
Overvaluation 8%
Multiples Across Competitors
Competitors Multiples
WuXi Biologics (Cayman) Inc Competitors
WuXi Biologics (Cayman) Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
140.6B HKD | 6.1 | 29.3 | 20.3 | 20.3 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
949.8B USD | 332.5 | 3 937.7 | 1 128.4 | 2 172.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
179B USD | 4 | 26.7 | 18.8 | 25.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
131.7B USD | 5.4 | 36.4 | 18.6 | 27 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.1B CHF | 5.1 | 35 | 26.1 | 26.1 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
262.9B CNY | 5.9 | 17.4 | 17.4 | 17.4 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.6B USD | 4.5 | 24.5 | 19.3 | 23 | |
| US |
|
Waters Corp
NYSE:WAT
|
27.8B USD | 8.8 | 43.2 | 27.9 | 35.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.6B USD | 1.7 | 20.4 | 11.5 | 17.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
23.8B USD | 5.9 | 27.4 | 20.4 | 22.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
